Dynavax Technologies
DVAX
#5495
Rank
C$1.76 B
Marketcap
C$15.04
Share price
-0.64%
Change (1 day)
-16.37%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -C$51.98 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$52.01 Million, an increase over its 2023 earnings that were of C$3.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$51.98 Million-199.93%
2024 C$52.01 M1475.31%
2023 C$3.3 M-99.2%
2022 C$0.41 B238.78%
2021 C$0.12 B-257.89%
2020 -C$77.61 Million-58.58%
2019 -C$0.19 Billion-9.32%
2018 -C$0.21 Billion60.44%
2017 -C$0.13 Billion-15.8%
2016 -C$0.16 Billion4.22%
2015 -C$0.15 Billion16.54%
2014 -C$0.13 Billion37.09%
2013 -C$91.86 Million
2010 -C$65.75 Million214.85%
2009 -C$20.89 Million-37.33%
2008 -C$33.33 Million-66.07%
2007 -C$98.22 Million16.92%
2006 -C$84 Million170.36%
2005 -C$31.07 Million33.39%
2004 -C$23.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
C$28.54 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.63 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.89 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.65 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.08 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
C$12.87 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$16.37 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.44 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$11.38 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA